Kazia Therapeutics (KZIA) EBT (2009 - 2011)

Kazia Therapeutics has reported EBT for 3 years, with the latest figure at -$932188.3 in Q4 2011.

• For the quarter ending Q4 2011, EBT rose 81.91% year-over-year to -$932188.3; the trailing twelve-month figure through Dec 2011 stood at -$932188.3 (up 81.91% YoY), and the FY2025 full-year result was -$14.4 million, up 19.35% from the prior year.
• EBT for Q4 2011 stood at -$932188.3, up from -$5.2 million in the prior quarter.
• The five-year high for EBT was -$932188.3 in Q4 2011, with the low at -$5.8 million in Q4 2009.
• Historically, EBT has averaged -$4.0 million across 3 years, with a median of -$5.2 million in 2010.
• Annual changes were most pronounced in 2010 — EBT increased 11.36% — and 2011, when it jumped 81.91%.
• Kazia Therapeutics' EBT stood at -$5.8 million in 2009, then climbed by 11.36% to -$5.2 million in 2010, then jumped by 81.91% to -$932188.3 in 2011.
• The last three EBT figures came in at -$932188.3 (Q4 2011), -$5.2 million (Q4 2010), and -$5.8 million (Q4 2009), per Business Quant data.